Jon E. Angell

Array ( [id] => 5935976 [patent_doc_number] => 20110212101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'MATERIALS AND METHODS FOR EXPLOITING SYNTHETIC LETHALITY IN MISMATCH REPAIR-DEFICIENT CANCERS' [patent_app_type] => utility [patent_app_number] => 12/674734 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28139 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212101.pdf [firstpage_image] =>[orig_patent_app_number] => 12674734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163464 [patent_doc_number] => 20110160280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'CANCER-RELATED GENES, CDCA5, EPHA7, STK31 AND WDHD1' [patent_app_type] => utility [patent_app_number] => 12/674659 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 81416 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160280.pdf [firstpage_image] =>[orig_patent_app_number] => 12674659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744622 [patent_doc_number] => 20120022128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis' [patent_app_type] => utility [patent_app_number] => 12/674664 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 37165 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022128.pdf [firstpage_image] =>[orig_patent_app_number] => 12674664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956154 [patent_doc_number] => 08501929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease' [patent_app_type] => utility [patent_app_number] => 12/673877 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 22 [patent_no_of_words] => 21176 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428600 [patent_doc_number] => 20090087910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'PRIMER-EXTENSION BASED METHOD FOR THE GENERATION OF siRNA/miRNA EXPRESSION VECTORS' [patent_app_type] => utility [patent_app_number] => 12/192356 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10087 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087910.pdf [firstpage_image] =>[orig_patent_app_number] => 12192356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007997 [patent_doc_number] => 20110060028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/673813 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11762 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060028.pdf [firstpage_image] =>[orig_patent_app_number] => 12673813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474447 [patent_doc_number] => 20090247613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/192878 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 66081 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247613.pdf [firstpage_image] =>[orig_patent_app_number] => 12192878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310251 [patent_doc_number] => 20090017532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Vector' [patent_app_type] => utility [patent_app_number] => 12/186839 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21294 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017532.pdf [firstpage_image] =>[orig_patent_app_number] => 12186839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336834 [patent_doc_number] => 20090053298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING CAR GENE EXPRESSION BY RNA INTERFERENCE' [patent_app_type] => utility [patent_app_number] => 12/183354 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10216 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053298.pdf [firstpage_image] =>[orig_patent_app_number] => 12183354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802362 [patent_doc_number] => 08440636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Micro-RNA family that modulates fibrosis and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/671445 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30928 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6182700 [patent_doc_number] => 20110179501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B' [patent_app_type] => utility [patent_app_number] => 12/671580 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30445 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20110179501.pdf [firstpage_image] =>[orig_patent_app_number] => 12671580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186717 [patent_doc_number] => 20110124712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'ANTI-CANCER COMPOSITION COMPRISING MICRORNA MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/599733 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7411 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124712.pdf [firstpage_image] =>[orig_patent_app_number] => 12599733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282683 [patent_doc_number] => 08216784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Cancer-derived microvesicle-associated microrna as a diagnostic marker' [patent_app_type] => utility [patent_app_number] => 12/524462 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20497 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311125 [patent_doc_number] => 20090018406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Method and Device for Assessing Carbohydrate-to-Insulin Ratio' [patent_app_type] => utility [patent_app_number] => 12/143601 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9237 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018406.pdf [firstpage_image] =>[orig_patent_app_number] => 12143601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759131 [patent_doc_number] => 08419649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Vital sign monitor for measuring blood pressure using optical, electrical and pressure waveforms' [patent_app_type] => utility [patent_app_number] => 12/138194 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 36 [patent_no_of_words] => 11272 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12138194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311141 [patent_doc_number] => 20090018422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'VITAL SIGN MONITOR FOR CUFFLESSLY MEASURING BLOOD PRESSURE USING A PULSE TRANSIT TIME CORRECTED FOR VASCULAR INDEX' [patent_app_type] => utility [patent_app_number] => 12/138199 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8045 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018422.pdf [firstpage_image] =>[orig_patent_app_number] => 12138199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6416693 [patent_doc_number] => 20100306869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'MODULATING PRODUCTION TRAITS IN AVIANS' [patent_app_type] => utility [patent_app_number] => 12/664097 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9982 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20100306869.pdf [firstpage_image] =>[orig_patent_app_number] => 12664097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 191037 [patent_doc_number] => 07642349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)' [patent_app_type] => utility [patent_app_number] => 12/157137 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34421 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642349.pdf [firstpage_image] =>[orig_patent_app_number] => 12157137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859607 [patent_doc_number] => 20080268457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'siRNA targeting forkhead box P3 (FOXP3)' [patent_app_type] => utility [patent_app_number] => 12/157152 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34392 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268457.pdf [firstpage_image] =>[orig_patent_app_number] => 12157152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410667 [patent_doc_number] => 20090124566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/134574 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 36616 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124566.pdf [firstpage_image] =>[orig_patent_app_number] => 12134574 [rel_patent_id] =>[rel_patent_doc_number] =>)